Background
Financial interactions between pharmaceutical companies and physicians can lead to conflicts of interest, potentially biasing physicians’ clinical practice. This study examines the extent and trends of non-research payments made by pharmaceutical companies to board-certified allergists in Japan between 2016 and 2020.